Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Long-term potentiation | R-HSA-9620244 | map04720 | gabapentin | 3446 | drug-path |
| Asthma | R-HSA-444620 | map05310 | gabapentin | 3446 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | gabapentin | 3446 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | gabapentin | 3446 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | gabapentin | 3446 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | gabapentin | 3446 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | gabapentin | 3446 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | gabapentin | 3446 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfadimethoxine | 6760 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfadimethoxine | 6760 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfadimethoxine | 6760 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | sulfadimethoxine | 6760 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | sulfadimethoxine | 6760 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | vidarabine | 21704 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | vidarabine | 21704 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | vidarabine | 21704 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | vidarabine | 21704 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | vidarabine | 21704 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ursodeoxycholic acid | 31401 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | ursodeoxycholic acid | 31401 | drug-path |